Lexicon Pharma (LXRX) Announces COO Departuree

On September 13, 2024, Lexicon Pharma (NASDAQ: LXRX) and Jeffrey L. Wade determined that his employment as our president and chief operating officer (in which capacity, Mr. Wade has functioned as our principal financial officer) would terminate as of September 30, 2024.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• NX3 Commercial Group Announces Private Charity Cocktail Reception Benefiting Grey Team
• Renfro Brands and Free Country Announce Exclusive Licensing Partnership for Socks